1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. France >
  5. Mediolanum Farmaceutici Acquires ElsaLys Biotech SA

M&A Deal Summary

Mediolanum Farmaceutici Acquires ElsaLys Biotech SA

On May 7, 2020, Mediolanum Farmaceutici acquired healthcare services company ElsaLys Biotech SA

Acquisition Highlights
  • This is Mediolanum Farmaceutici’s 1st transaction in the Healthcare Services sector.
  • This is Mediolanum Farmaceutici’s 1st transaction in France.

M&A Deal Summary
Date 2020-05-07
Target ElsaLys Biotech SA
Sector Healthcare Services
Buyer(s) Mediolanum Farmaceutici
Deal Type Add-on Acquisition

Target

ElsaLys Biotech SA

Lyon, France
ElsaLys Biotech SA is a provider of novel treatment solutions to patients, with a particular focus on whom the current therapies are less or no longer beneficial. ElsaLys Biotech is based in Lyon, France.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Mediolanum Farmaceutici

Milan, Italy
Category Company
Founded 1972
Sector Life Science
DESCRIPTION

Mediolanum Farmaceutici is a pharmaceutical company focused on serving customers from the Italian cardiovascular market. Mediolanum Farmaceutici was founded in 1972 and is based in Milan, Italy.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-28 Neopharmed Gentili

Milan, Italy

Neopharmed Gentili is an Italian pharmaceutical group focused on the research, development, production, and distribution of medicines in many therapeutic areas such as vascular and cardio-metabolic areas, pneumatological areas, antibiotics, OTCs, and supplements. Neopharmed Gentili was founded in 2011 and is based in Milan, Italy.

Sell -
Mergr

Solution for

Product

Company

Legal